These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8171323)

  • 1. A lymphotoxin-beta-specific receptor.
    Crowe PD; VanArsdale TL; Walter BN; Ware CF; Hession C; Ehrenfels B; Browning JL; Din WS; Goodwin RG; Smith CA
    Science; 1994 Apr; 264(5159):707-10. PubMed ID: 8171323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs.
    Rennert PD; Browning JL; Mebius R; Mackay F; Hochman PS
    J Exp Med; 1996 Nov; 184(5):1999-2006. PubMed ID: 8920886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.
    Browning JL; Ngam-ek A; Lawton P; DeMarinis J; Tizard R; Chow EP; Hession C; O'Brine-Greco B; Foley SF; Ware CF
    Cell; 1993 Mar; 72(6):847-56. PubMed ID: 7916655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
    Rennert PD; Browning JL; Hochman PS
    Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
    Li DH; Havell EA; Brown CL; Cullen JM
    Gene; 2000 Jan; 242(1-2):295-305. PubMed ID: 10721723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA.
    Sarrias MR; Whitbeck JC; Rooney I; Ware CF; Eisenberg RJ; Cohen GH; Lambris JD
    Mol Immunol; 2000 Aug; 37(11):665-73. PubMed ID: 11164894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
    Force WR; Walter BN; Hession C; Tizard R; Kozak CA; Browning JL; Ware CF
    J Immunol; 1995 Dec; 155(11):5280-8. PubMed ID: 7594541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
    Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kappa B family members.
    Voon DC; Subrata LS; Karimi M; Ulgiati D; Abraham LJ
    J Immunol; 2004 Apr; 172(7):4332-41. PubMed ID: 15034048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
    Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
    J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of lymphotoxin-beta by tumor necrosis factor, phorbol myristate acetate, and ionomycin in Jurkat T cells.
    Voon DC; Subrata LS; Abraham LJ
    J Interferon Cytokine Res; 2001 Nov; 21(11):921-30. PubMed ID: 11747624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta.
    Browning JL; Miatkowski K; Griffiths DA; Bourdon PR; Hession C; Ambrose CM; Meier W
    J Biol Chem; 1996 Apr; 271(15):8618-26. PubMed ID: 8621492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.